Day: June 27, 2022
– First company to Convert from Secondary to Primary Listing Status in Hong Kong
– Our dual Primary Listing on the Nasdaq and Hong Kong Stock Exchange provides greater access for investors
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., June 27, 2022 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that it has completed its voluntary conversion of its secondary listing status to a primary listing on the Main Board of The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock Exchange”). Zai Lab is now a dual-primary listed company on both Nasdaq and the Hong Kong Stock Exchange.
“As we execute our globalization and growth strategy, we are pursuing new ways to attract potential investors who share Zai Lab’s vision...
Achiko AG Announces Annual Results for the Year Ended December 31, 2021
Written by Customer Service on . Posted in Public Companies.
ZURICH, Switzerland, June 26, 2022 (GLOBE NEWSWIRE) — Achiko AG (OTCQB: ACHKF; SIX: ACHI; ISIN CH0522213468) (“Achiko”, the “Company”) announces its financial results for the year ended December 31, 2021, and progress since then.
For the year ended December 31, 2021, the Group recorded a net loss of USD $9,231,779 resulting in an increase of the Group’s accumulated losses to USD $34,568,395. The Company also notes that Achiko AG is currently managing creditors, and that while the assets of the Group at the reporting date was negative $4.584m, it also has over $2.4m in subordinated loans.
As a result, the Company’s auditors have given an adverse opinion, noting the Company’s ability to remain a going concern depends on the successful approval of an increase in Authorised Capital at the upcoming General Meeting, and the support of...